LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Oxford, JSR Corp Partner to Advance Platform in Asia
Company News

Oxford, JSR Corp Partner to Advance Platform in Asia

May 25, 2018 1 min read Premium comments

Advertisement

Oxford, JSR Corp Partner to Advance Platform in Asia
OPM OsteoFab Technology / Courtesy of Oxford Performance Materials, Inc.
#oxfordperformancematerialsSecondary#JSRcorp

Oxford Performance Materials, Inc. (OPM), an advanced materials science and high performance additive manufacturing (HPAM) company based in South Windsor, Connecticut, has partnered with Tokyo, Japan-based JSR Corporation (JSR), a materials supplier, to advance OPM’s poly-ether-ketone-ketone (PEKK)-based 3D-printed orthopedic devices and biomedical and dental materials businesses throughout Asia.

The two companies “…will establish operations in Japan as ‘OPM Asia,’ with an exclusive regional license to exploit OPM’s proprietary OsteoFab biomedical device 3D printing technology and OXPEKK materials technology.” JSR will supply the equity capital for OPM Asia. “The OPM Asia license will cover a broad territory consisting of Japan, China, Taiwan, Korea, Brunei Darussalam, Cambodia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam and India.”

Scott DeFelice is CEO of Oxford Performance Materials. He told OTW, “JSR is committed to building a personalized medicine ecosystem and OPM is a pioneer in personalized medicine as the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants. This partnership is an ideal fit to advance OPM’s technology platform throughout Asia and to further strengthen JSR’s personalized medicine capabilities.”

“This partnership will bring cost-effective medical innovation to patients in one of the fastest growing healthcare markets in the world, enabling the Asian orthopedics industry to improve patient outcomes at a lower cost.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy